Latest Blog Posts
FDA Announces Recall of Hair Loss Medication
| May 12th, 2020
According to a statement published by the U.S. Food and Drug Administration on May 11, 2020, 1 lot of Finasteride Plus 1.25 mg, a medication designed to treat hair loss, is being recalled by its manufacturer MasterPharm, LLC. The recall is due to the medication containing undeclared amounts of minoxidil, which exceed those found in
Read MoreWhere Can You Learn About Drug Recalls?
| May 5th, 2020
At Ferrer, Poirot & Wansbrough, it’s our job to help people harmed by defective and recalled medications get the compensation they deserve. But our years of experience has taught us that many patients aren’t aware that their medications have been recalled until it’s too late. Unfortunately, it’s not uncommon for drug recalls to be underreported,
Read More3 Eye-Opening Statistics about Prescription Medications
| April 28th, 2020
Think of a health condition, disease, or illness. Chances are, whatever you came up with, no matter how obscure it is, there’s a prescription medication designed to treat it. The pharmaceutical industry is big, big business, both in America and worldwide. Prescription drugs treat conditions ranging from common colds and muscle aches to cancer and
Read MoreWhat is NDMA and Why is It in Many Recalled Drugs?
| April 21st, 2020
On April 15, 2020, the U.S. Food and Drug Administration posted a notice on its website that a Nizatidine Oral Solution 15 mg/mL product was recalled due to containing high levels of nitrosodimenthylamine (NDMA). The product is manufactured by Amneal Pharmaceuticals, LLC, and distributed by its subsidiary Gemini Laboratories, LLC. NDMA is classified as a
Read More